DKK-3 and WIF-1: Proteins related to liver cancer development?

Jun 15, 2009

Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year. The current methods used to monitor such high-risk groups include ultrasound scans and a test for the presence of a single protein in the blood called alpha-fetoprotein. It is a good indicator of advanced liver cancer, but less able to detect early disease. So it is the most impotent thing is find the changes of biomarker combinations in the early period of diseases, control the key gene in the initial stage of disease and reverse the development of disease.

Wnt signal transduction pathway was significantly related to human neoplastic transformation. The Wnt-antagonist genes function as tumor suppressors and contribute to the pathogenesis of several human malignancies. Such as the promoter-hypermethylation and reduced expression of the DKK-3 gene was found in bladder cancer, lung cancer cell lines and tissues, the WIF-1 gene was found in lung cancer cell lines and tissues, malignant pleural mesothelioma cell lines and tissues, and nasopharyngeal cancer cell lines, also.

A research article to be published in the World Journal of Gastroenterology addresses this question. The study suggested the proteins transcripted by DKK-3 and WIF-1 can act as cancer-associated proteins relate with development, but it isn't the same mechanism with (HBV) infection reducing the liver cancer development. The author identified that the silence of DKK-3 and WIF-1 gene resulted from the hypermethylation of its promoter maybe one of carcinogenic factors related to age and apart from HBV infection and the expression of DKK-3 is negatively related to the stage of tumor and cell proliferation. All of this suggested DKK-3 and WIF-1 have great potential to be identified as cancer-associated proteins in the liver . It may be provide a reliable way to improve liver cancer early diagnosis and new therapies by blocking this pathway to treatment of liver cancer through further study.

Source: World Journal of Gastroenterology (news : web)

Explore further: ACG: Recent increase in incidence of young-onset CRC

add to favorites email to friend print save as pdf

Related Stories

Candidate markers for gastric cancer

Oct 29, 2008

The sequencing of the human genome has opened the door for proteomics by providing a sequence-based framework for mining proteomes. As a result, there is intense interest in applying proteomics to foster a better understanding ...

In 'spontaneous' liver cancer, researcher sees a cure

Jun 20, 2007

Adding more good news to last week’s announcement that Nexavar® (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University ...

Genetic signature predicts outcome of pediatric liver cancer

Dec 08, 2008

Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children. The research, published by Cell Press in the December issue of the journal ...

If metastasectomy should be performed before other treatments

Oct 31, 2008

Primary HCC is a major cancer related to HBV viral infection in Asian countries, including Japan. Recently, the primary liver cancers are successfully treated by surgical resection including liver transplantation and non-surgical ...

New test improves detection of liver cancer

Aug 08, 2007

Cancer of the liver is very difficult to detect, and it is a major cause of death in Asia and Africa, with rising incidence in Western countries as well. Now, VIB researchers connected to Ghent University, in collaboration ...

Recommended for you

ACG: Recent increase in incidence of young-onset CRC

17 minutes ago

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments : 0